FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 350:1997-1999 May 6, 2004 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Cooper, J. S. Related Article by Bernier, J. PubMed Citation

Squamous-cell cancer of the head and neck is the sixth most common cancer worldwide, with a lifetime risk of 2 percent for men and 0.6 percent for women. There are approximately 76,000 and 37,000 new cases of oral-cavity, pharyngeal, and laryngal cancer diagnosed each year in Western Europe and the United States, respectively. The presence or absence of local and regional disease primarily determines the treatment outcome among these patients. Nonetheless, although the incidence of distant metastases is relatively low, as compared with that of other cancers of the upper aerodigestive tract, distant metastases will develop in almost one third . . . [Full Text of this Article]

Source Information

From the Academic Department of Oncology, University College London, London (M.I.S.), and the Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex, United Kingdom (M.I.S., A.R.).

This article has been cited by other articles:

• Nagaraj, N. S. (2009). Evolving 'omics' technologies for diagnostics of head and neck cancer. Brief Funct Genomic Proteomic 0: elp004v1-elp004 [Abstract] [Full Text]